Cliquez pour consulter notre déclaration sur l'accessibilité

Recherches populaires

Photo de Marika Miller.

Marika Miller

Associé

Retour

Marika Miller

Associé

Chicago 312.832.4901

Secteurs

Domaines d'activité

L'éducation

  • Loyola University Chicago School of Law (J.D. & Health Law Certificate)
    • Leadership, Service, and Public Interest Recognition Award
  • Loyola University Chicago (B.S.)

Admissions

  • Illinois

Marika Miller is a telehealth and healthcare regulatory lawyer and is a member of the firm’s national Telemedicine & Digital Health Industry Team. She advises start-up and established telehealth and digital health companies, physician groups, hospitals and health systems, pharmacies, and other health care providers on health care regulatory and compliance matters.

Marika’s expertise is focused on state professional and facility standards and reimbursement considerations for health care providers, whether their practice is virtual, brick-and-mortar, or a hybrid model. Marika provides strategic, comprehensive advice on telehealth professional standards, such as licensure, permitted telehealth modalities, consent requirements, and the nuances of establishing a provider-patient relationship and prescribing via telehealth. She is well-versed in provider and facility licensure, scope of practice, supervision and collaborative practice requirements, and the corporate practice doctrine. Her practice also involves guiding clients through Medicare and Medicaid enrollment while advising telehealth providers on potential barriers to practice, such as in-state location requirements, covered telehealth modalities, and billing and reimbursement issues.

Marika is dedicated to delivering practical and comprehensive solutions that help clients navigate multi-state regulatory demands and achieve operational efficiency. Leveraging her extensive experience, she assists clients in adapting to legal and regulatory changes and the evolving telehealth and digital health landscape. Her approach focuses on providing scalable solutions that enable clients to expand their services effectively and sustainably.

Affiliations

  • Membre de l'American Health Lawyers Association
  • Member, Illinois Association of Healthcare Attorneys
  • Member, American Telemedicine Association

Publications et présentations

  • Author, “Medicare Telehealth Flexibilities Have Expired,” Health Care Law Today (October 1, 2025)
  • Author, “Medicare Telehealth Flexibilities: Countdown to September 30, 2025,” Health Care Law Today (September 11, 2025)
  • Co-author, “CY 2026 Medicare PFS Proposed Rule: Telehealth Takeaways,” Health Care Law Today (August 19, 2025)
  • Co-author, “Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM): What You Need to Know About CMS’ Proposed Changes,” Health Care Law Today (July 30, 2025)
  • Author, “What’s Next for Telehealth and Digital Health Policy? Five Trends to Watch in 2025,” Health Care & Life Sciences Top Trends for 2025 (March 25, 2025)
  • Co-author, “DEA Buprenorphine Rule Delayed to December 31, 2025,” Health Care Law Today (March 25, 2025)
  • “What DEA’s special registrations mean for telehealth prescribing,” TechTarget (February 20, 2025) (quoted)
  • “What DEA’s special registrations mean for telehealth prescribing,” Xtelligent Virtual Healthcare (February 20, 2025) (quoted)
  • Speaker, “Status Update: Medicare Telehealth Reimbursement,” Kentucky Rural Telehealth Summit (February 19, 2025)
  • “DEA, HHS delay effective date of virtual OUD prescribing rule to March,” Fierce Healthcare (February 18, 2025) (quoted)
  • Co-author, “DEA Delays Final Buprenorphine Rule,” Health Care Blog (February 18, 2025)
  • “The fate of virtual OUD treatment lies in a mess of intertwined final and proposed regulations,” Fierce Healthcare (February 7, 2025) (quoted)
  • “Pandemic Expansion of Medicare Telehealth Coverage Set to End March 31,” Pulmonology Advisor (January 31, 2025) (quoted)
  • “Prescribing Pullback: Telehealth Advocates Ask Trump to Withdraw DEA Proposal,” healthleaders (January 22, 2025) (quoted)
  • Co-author, “DEA Unveils Long-Overdue Special Registration for Telemedicine in Proposed Rule,” Health Care Law Today (January 21, 2025)
  • “DEA Proposes a Special Registry for Telehealth Providers of Controlled Substances,” MedPage Today (January 16, 2025) (quoted)
  • Co-auteur, "DEA Tightens Buprenorphine Telemedicine Prescribing Rules", Health Care Law Today (16 janvier 2025)
  • “DEA unveils telehealth rules for Adderall, buprenorphine, other controlled medications,” STAT (January 15, 2025) (quoted)
  • Co-author, “Medicare Telehealth Flexibilities Get a Three-Month Lifeline,” Health Care Law Today (December 23, 2024), republished in Chicago Medicine’s February 2025 issue
  • Co-author, “New DEA Rule Extends Controlled Substance Telemedicine Prescribing Flexibilities One More Year,” Health Care Law Today (November 18, 2024)
  • Co-author, “New DEA Rule Expected to Extend Controlled Substance Telemedicine Prescribing Flexibilities Through 2025,” Health Care Law Today (October 17, 2024)
Gros plan d'un trombone fixant une carte d'assurance maladie et des documents, avec le mot "Medicare" clairement visible - une image que l'on voit souvent dans un cabinet d'avocats d'entreprise ou parmi les avocats de Chicago qui traitent des informations sensibles sur leurs clients.
October 1, 2025 Health Care Law Today

La flexibilité de la télésanté dans le cadre de Medicare a expiré

With no FY 2026 spending bill passed, the government shutdown triggered a rollback to pre-pandemic Medicare telehealth reimbursement policies, limiting patient locations and eligible providers and requiring in-person visits at certain intervals for mental health services; find a summary here.
Une personne tape sur un ordinateur portable, un stéthoscope étant posé sur le bureau au premier plan, ce qui met en évidence l'intersection du droit de la santé et du droit de la propriété intellectuelle.
11 septembre 2025

Flexibilités en matière de télésanté dans le cadre de Medicare : Compte à rebours jusqu'au 30 septembre 2025

Dans l'état actuel des choses, il n'est pas certain que les flexibilités de Medicare en matière de télésanté soient prolongées. Bien que le Congrès soit confronté à des contraintes budgétaires strictes et à des priorités concurrentes, le maintien de l'accès à la télésanté continue de bénéficier d'un fort soutien bipartisan, ce qui rend une nouvelle prolongation probable, mais non garantie. Nous examinons ci-dessous les enjeux, les mesures qui sont actuellement à l'étude et ce que les acteurs de la télésanté peuvent faire pour faire avancer les choses.
image en vedette
19 août 2025 La loi sur les soins de santé aujourd'hui

CY 2026 Medicare PFS Proposed Rule : La télésanté à retenir

En juillet 2025, les Centers for Medicare & Medicaid Services (CMS) ont publié la règle proposée CY 2026 Medicare Physician Fee Schedule (PFS)....
image en vedette
July 30, 2025 Health Care Law Today

Surveillance à distance des patients (RPM) et surveillance thérapeutique à distance (RTM) : Ce qu'il faut savoir sur les changements proposés par la CMS

On July 14, 2025, the Centers for Medicare and Medicaid Services (CMS) proposed key changes to remote patient monitoring (RPM) and remote...
A person in medical scrubs uses a tablet at a white desk, wearing a smartwatch and an ID badge. Their face is not visible, suggesting routine tech use in busy law offices or even a corporate law office environment.
May 3, 2025 Events

Foley & Lardner at ATA Nexus 2025: Advancing Innovation in Digital Health
A stethoscope rests on a calendar with a pen and notebook nearby, suggesting scheduled healthcare planning—much like how law offices coordinate appointments for lawyers in Chicago.
March 25, 2025 Health Care Law Today

DEA Buprenorphine Rule Delayed to December 31, 2025

The U.S. Department of Health and Human Services and the Drug Enforcement Administration have postponed the effective date of the final rule regarding telemedicine prescribing of buprenorphine to December 31, 2025.
Voir tous les points de vue
Voir la salle de presse